astrazeneca is moving quickly with covid antibody drug, ceo says
Published 1 year ago • 284 plays • Length 3:04Download video MP4
Download video MP3
Similar videos
-
1:39
astrazeneca and u.s. strike deal to develop covid-19 antibody drug supply
-
0:33
astrazeneca surges after hhs provides $500 million for covid-19 antibody treatment development
-
7:27
astrazeneca ceo on covid-19 vaccine efforts, barda funding and more
-
3:00
coronavirus 'a lot more contagious than flu,' astrazeneca ceo says | street signs europe
-
3:44
not clear yet if we need a third booster for the vaccine: astrazeneca ceo
-
9:40
how i work 5 hours a week & make $1.6 million a year
-
17:57
how biontech used cancer research to create its covid vaccine
-
12:16
how unitedhealth grew larger than the biggest u.s. bank
-
1:19
astrazeneca's antibody cocktail helps prevent covid for at least 6 months
-
3:23
the developing world could use astrazeneca's coronavirus vaccine, says johns hopkins doctor
-
3:14
astrazeneca ceo addresses coronavirus trial pause
-
7:47
who: delay in astrazeneca coronavirus vaccine trial is a 'wake up call'
-
6:20
who on oxford-astrazeneca coronavirus vaccine data: it is good news
-
4:48
astrazeneca executive explains positive covid-19 vaccine results
-
8:14
astrazeneca down after report that covid-19 vaccine is put on hold
-
11:26
what's going wrong with the eu's vaccine rollout? | cnbc reports
-
3:33
eli lilly reports results from covid-19 phase 2 antibody drug trial
-
4:14
astrazeneca covid antibody cocktail only 33% effective
-
2:40
astrazeneca ceo awaits diagnosis on covid-19 trial participant who developed neurological condition
-
2:25
oxford-astrazeneca covid-19 vaccine approved by u.k. regulator
-
3:05
astrazeneca vaccine found to be 79% effective in u.s. study
-
27:34
gilead's moving quickly with fda for approval of coronavirus drug remdesivir: ceo